Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LISA for RDS in Nigeria
NCT05714865Phase 4Completed
- Sponsor
- Indiana University
- Start
- Jun 2023
- Primary completion
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of BLES in respiratory distress syndrome (RDS), sponsored by Indiana University. Started Jun 2023; status: completed.
02
Drugs
BLES
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT05714865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05714865.